Erzincan Binali Yıldırım ÜniversitesiErzincan Binali Yıldırım ÜniversitesiAçık Erişim Arşivi · RDL Open

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)

CorrectionAçık Erişim

Özet

Following publication of the original article [1], the authors reported an error in the author name of Enes Erul. Incorrect: Enes Urul Correct: Enes Erul, The original article [1] has been corrected. © 2023, The Author(s).

Anahtar Kelimeler

erratum
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11966Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/s12885-023-10662-3Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKaracin, Cengiz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorDemirci, Ayşe
dc.contributor.authorKeskinkılıç, Merve
dc.contributor.authorBaytemür, Naziyet Köse
dc.contributor.authorYılmaz, Funda
dc.contributor.authorSelvi, Oğuzhan
dc.contributor.authorErdem, Dilek
dc.contributor.authorAvşar, Esin
dc.contributor.authorPaksoy, Nail
dc.contributor.authorDemir, Necla
dc.contributor.authorGöksu, Sema Sezgin
dc.contributor.authorTürker, Sema
dc.contributor.authorBayram, Ertuğrul
dc.contributor.authorÇelebi, Abdüssamet
dc.contributor.authorYılmaz, Hatice
dc.contributor.authorKuzu, Ömer Faruk
dc.contributor.authorKahraman, Seda
dc.contributor.authorGökmen, İvo
dc.contributor.authorSakin, Abdullah
dc.contributor.authorAlkan, Ali
dc.contributor.authorNayır, Erdinç
dc.contributor.authorUğraklı, Muzafer
dc.contributor.authorAcar, Ömer
dc.contributor.authorErtürk, İsmail
dc.contributor.authorDemir, Hacer
dc.contributor.authorAslan, Ferit
dc.contributor.authorSönmez, Özlem
dc.contributor.authorKorkmaz, Taner
dc.contributor.authorCelayir, Özde Melisa
dc.contributor.authorKaradağ, İbrahim
dc.contributor.authorKayıkçıoğlu, Erkan
dc.contributor.authorŞakalar, Teoman
dc.contributor.authorÖktem, İlker Nihat
dc.contributor.authorEren, Tülay
dc.contributor.authorErul, Enes
dc.contributor.authorMocan, Eda Eylemer
dc.contributor.authorKalkan, Ziya
dc.contributor.authorYıldırım, Nilgün
dc.contributor.authorErgün, Yakup
dc.contributor.authorAkagündüz, Baran
dc.contributor.authorKarakaya, Serdar
dc.contributor.authorKut, Engin
dc.contributor.authorTeker, Fatih
dc.contributor.authorDemirel, Burçin Çakan
dc.contributor.authorKaraboyun, Kubilay
dc.contributor.authorAlmuradova, Elvina
dc.contributor.authorÜnal, Olçun Ümit
dc.contributor.authorOyman, Abdilkerim
dc.contributor.authorIşık, Deniz
dc.date.accessioned2026-10-18T20:26:56.217425736Z
dc.date.available2026-10-18T20:26:56.217425736Z
dc.date.issued2023
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the author name of Enes Erul. Incorrect: Enes Urul Correct: Enes Erul, The original article [1] has been corrected. © 2023, The Author(s).
dc.identifier.doi10.1186/s12885-023-10662-3
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.pmcidPMC9969671
dc.identifier.pmid36849943
dc.identifier.scopus2-s2.0-85148970683
dc.identifier.startpage192
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11966
dc.identifier.volume23
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Cancer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjecterratum
dc.titleCorrection: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)
dc.typeCorrection
dspace.entity.typePublication
rdl.citation.scopus1
rdl.departmentDepartment of Medical Oncology, Erzincan Binali Yıldırım University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexPUBMED